46 results
Zalicus, Inc. (Nasdaq: ZLCS) has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (“Lincoln Park”) an institutional investor. Under the terms of the agreement, Zalicus has the right to sell up to $25,000,000 in shares of its ...StreetInsider · 5/8/2013
The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.07) by $0.01, Stock Ratings Network reports. The company had revenue of $3.70 million for the quarter, compared to the consensus estimate of $3.Daily Political · ByStacy Sanders · 5/2/2013
Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has entered into a stock purchase agreement with Lincoln Park Capital ...MSN Money · 5/8/2013
Zalicus secures new $25 mln funding commitment from Lincoln Park Capital Co announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund an institutional investor. Under the terms of the agreement, Zalicus has the ...MSN Money · 5/8/2013
Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund ...4-traders · 5/8/2013
PRESS RELEASE Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has entered into a stock purchase agreement with Lincoln …Private Equity Hub · 5/8/2013
Zalicus Inc. (Nasdaq Capital Market: ZLCS) today announced that preclinical data highlighting its novel, oral ion channel programs for the treatment of pain including Z160, an N-type calcium channel blocker and Z944, a T-type calcium channel ...Boston.com · 5/10/2013
But now might be the time value biotech investors take a look at the stock. The currently market capitalization is only $75 million. That's less than five times our projected 2013 revenues of $16.3 million, and 33% of the market capitalization is supported ...Seeking Alpha · 5/2/2013
Thus far today, Zalicus has traded 498,000 shares, vs. average volume of 468,000 shares per day. The stock has underperformed the Dow (-6.1% to the Dow's -0.4%) and underperformed the S&P 500 (-6.1% to the S&P's -0.2%) during today's trading. Zalicus ...TMCnet.com · 4/22/2013
Zalicus (NASDAQ: ZLCS)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a research note issued to investors on Wednesday. They currently have a $2.00 price target on the stock. The analysts wrote ...Daily Political · ByJeff Wilder · 3/6/2013
POPULAR NOW
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback